Read More 13 minute read Intraday Update Markets Movers News Options Trading Ideas Stocks That Hit 52-Week Lows On Friday By Benzinga Insights Today, 10:41 PM During Friday's morning session, 234 stocks hit new 52-week lows. ACIW
Read More 1 minute read Analyst Ratings News Price Target SVB Leerink Maintains Outperform on Vincerx Pharma, Lowers Price Target to $20 By Benzinga Newsdesk Today, 10:41 PM SVB Leerink analyst Jonathan Chang maintains Vincerx Pharma (NASDAQ:VINC) with a Outperform and lowers the price target from $24 to $20. VINC
Read More 1 minute read Analyst Ratings News Price Target HC Wainwright & Co. Maintains Buy on Vincerx Pharma, Raises Price Target to $28 By Benzinga Newsdesk Today, 10:41 PM HC Wainwright & Co. analyst Michael King maintains Vincerx Pharma (NASDAQ:VINC) with a Buy and raises the price target from $25 to $28. VINC
Read More 1 minute read Earnings News Vincerx Pharma Q4 EPS $0.31 By Benzinga Newsdesk Today, 10:41 PM Vincerx Pharma (NASDAQ:VINC) reported quarterly earnings of $0.31 per share. VINC
Read More 22 minute read Intraday Update Markets Movers News Options Trading Ideas Stocks That Hit 52-Week Lows On Friday By Benzinga Insights Today, 10:41 PM On Friday, 368 stocks hit new 52-week lows. AAL
Read More 19 minute read Intraday Update Markets Movers News Options Trading Ideas Stocks That Hit 52-Week Lows On Friday By Benzinga Insights Today, 10:41 PM On Friday, 313 companies hit new 52-week lows. AAON
Read More 10 minute read Intraday Update Markets Movers News Options Trading Ideas Stocks That Hit 52-Week Lows On Thursday By Benzinga Insights Today, 10:41 PM On Thursday, 147 companies achieved new lows for the year. AFRM
Read More 1 minute read News Offerings Vincerx Pharma Announces Offering Of $150M In Common Stock By Benzinga Newsdesk Today, 10:41 PM -SEC Filing VINC
Read More 25 minute read Intraday Update Markets Movers News Options Trading Ideas Stocks That Hit 52-Week Lows On Friday By Benzinga Insights Today, 10:41 PM During Friday's session, 445 companies made new 52-week lows. AAOI
Read More 1 minute read Analyst Ratings Initiation News Price Target Cantor Fitzgerald Initiates Coverage On Vincerx Pharma with Overweight Rating, Announces Price Target of $25 By Benzinga Newsdesk Today, 10:41 PM Cantor Fitzgerald analyst Li Watsek initiates coverage on Vincerx Pharma (NASDAQ:VINC) with a Overweight rating and announces Price Target of $25. VINC